Skip to content

Vira Regen

1 viewer · 30d

Total raised

1 filing since 2026 · no dollar figures disclosed

No disclosed amounts to chart
LAST ROUND
Equity
ROUNDS
1
INVESTORS
N/A
FOUNDED
2023
HQ
Salt Lake City, UT
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Vira Regen Inc. is a Salt Lake City biotech developing gene-specific bioelectronic medicines — noninvasive electroceuticals that use electrical stimulation to switch on the body's own regenerative genetic pathways. The company uses computational biology and custom machine learning to target specific genetic pathways on demand rather than applying undifferentiated stimulation. Its lead program is a bone growth stimulator for accelerated fracture repair, developed with roughly $2 million in nondilutive U.S. Department of Defense funding awarded through MTEC for military and civilian applications. The company is pursuing a Breakthrough Device Designation for its gene-targeted stimulation approach.

What sets it apart

Gene-specific rather than general electrical stimulation: computational biology and machine learning are used to control which genetic pathways the device activates, aiming at targeted tissue regeneration through a noninvasive device rather than a drug.

Funding history

1 round
EquityMar 13, 2026
Form D
total

Latest SEC filings

via EDGAR · CIK 0002115222
Form D · Mar 13, 2026View on EDGAR

Products

1 tracked

Gene-targeted bone growth stimulator

Bioelectronic medical device

A noninvasive electroceutical device that applies gene-specific bioelectric stimulation to accelerate bone regeneration in traumatic fractures and orthopedic recovery. It is the company's lead program, developed with Department of Defense support, and is being advanced toward a Breakthrough Device Designation.

  • Noninvasive electrical stimulation
  • Gene-specific pathway targeting rather than undifferentiated stimulation
  • Computational biology and custom machine learning to control which pathways activate
  • Developed for both military trauma and civilian orthopedic use